Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.

Emma Camacho-UrkarayJorge Santos-JuanesFrancisco Borja Gutiérrez-CorresBeatriz GarcíaLuis M QuirósIsabel Guerra-MerinoJosé Javier AguirreIvan Fernandez-Vega

Published in: Cellular oncology (Dordrecht) (2017)

Correlations between protein biomarkers and main clinical GBM variables were identified. The establishment of distinct biomarker cut-off points may enable clinicians and pathologists to better weigh their prognostic value.

Keyphrases

poor prognosis
binding protein
stem cells
transcription factor
cell cycle
palliative care
protein protein
amino acid
cell cycle arrest
cell death
small molecule
pi k akt